145 related articles for article (PubMed ID: 38112020)
1. Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy.
Xu W; Yang J; Ye S; Liu W; Lu J; Anwaier A; Zhang H; Ye D
Immunotherapy; 2024 Feb; 16(3):131-134. PubMed ID: 38112020
[No Abstract] [Full Text] [Related]
2. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J; J T; Sl N; Gt B
Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of tertiary lymphoid structures in cancer.
You X; Koop K; Weigert A
Front Immunol; 2023; 14():1286850. PubMed ID: 38111571
[TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J; Chen J; Wang L
J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
[TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.
Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A
Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486
[TBL] [Abstract][Full Text] [Related]
6. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
Tang H; Qiu X; Timmerman C; Fu YX
Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
[TBL] [Abstract][Full Text] [Related]
7. [Rethinking the place of B lymphocyte and tertiary lymphoid structures in oncoimmunotherapy].
Germain C; Kaplon H; Dieu-Nosjean MC
Med Sci (Paris); 2021 Feb; 37(2):130-133. PubMed ID: 33591255
[No Abstract] [Full Text] [Related]
8. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.
Jia W; Zhang T; Yao Q; Li J; Nie Y; Lei X; Mao Z; Wang Y; Shi W; Song W
Front Immunol; 2022; 13():870458. PubMed ID: 35844587
[TBL] [Abstract][Full Text] [Related]
9. Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.
Lin L; Hu X; Zhang H; Hu H
Front Immunol; 2019; 10():1398. PubMed ID: 31281318
[TBL] [Abstract][Full Text] [Related]
10. Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis.
Lee M; Heo SH; Song IH; Rajayi H; Park HS; Park IA; Kim YA; Lee H; Gong G; Lee HJ
Mod Pathol; 2019 Jan; 32(1):70-80. PubMed ID: 30154578
[TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer.
Zhou L; Xu B; Liu Y; Wang Z
Oncoimmunology; 2021 May; 10(1):1915574. PubMed ID: 34104539
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structures in the era of cancer immunotherapy.
Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
[TBL] [Abstract][Full Text] [Related]
13. [Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].
Fridman WH; Petitprez F; Sautes-Fridman C
Bull Cancer; 2020 Apr; 107(4):403-404. PubMed ID: 32284150
[No Abstract] [Full Text] [Related]
14. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract][Full Text] [Related]
15. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
17. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
[TBL] [Abstract][Full Text] [Related]
18. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
19. Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?
Fridman WH; Sibéril S; Pupier G; Soussan S; Sautès-Fridman C
Semin Immunol; 2023 Jan; 65():101703. PubMed ID: 36481358
[TBL] [Abstract][Full Text] [Related]
20. [Recent Progress of Tertiary Lymphoid Structure in Prognosis and Immunotherapy of Non-small Cell Lung Cancer].
Liu Y; Xiong L; Cai R; Chen Y; Ye J; Shen B; Zhou G
Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):615-620. PubMed ID: 37752541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
